OrthoSpineNews

MAY 13, 2025

Mr. Silvas ISCT presentation, titled Phase 2 Clinical Safety/Efficacy Data of Intradiscal Injection of Hypoxic Mesenchymal Stem Cells for Lumbar Disc Disease, can be accessed on the Companys new website under Scientific Publications in the Product Candidate section. 12 13.33% 26 46.15% 52 70.0%

Degenerative Disc Disease 52

Degenerative Disc Disease Lower Back Pain Clinic Treatment 52

Any Spine

OCTOBER 1, 2024

Occurrences of degenerative disc disease are common where the intervertebral discs lose their flexibility, leading to chronic back pain and reduced mobility. Conditions like degenerative disc disease, spinal disc herniation , and spinal stenosis are significant contributors.

Spine 52

Spine Degenerative Disc Disease Chiropractic Spinal Adjustment 52

Any Spine

OCTOBER 22, 2024

For those providing care, whether in a professional nursing capacity or as family members, chronic pain presents an ongoing challenge that stretches resources and emotional resilience. It is a pervasive disease, silently exacting its toll on the physical and mental well-being of sufferers and their support systems alike.

Back Pain Relief 98

Back Pain Relief Chiropractic Care Chiropractic Spinal Manipulation 98

Any Spine

NOVEMBER 7, 2024

Initial Health Assessment and Consultation During your initial consultation at our studio, I’ll conduct a comprehensive review of your posture and movement patterns to reveal underlying contributors to conditions like degenerative disc disease or persistent scar-related discomfort.

Massage 52

Massage Chiropractors Chiropractor Migraine 52

Any Spine

SEPTEMBER 29, 2024

Furthermore, the reliance on medications such as opioids for spine pain relief presents a significant concern due to the risk of dependency and side effects. As such, this persistent pain often escalates into a hindrance that demands effective management strategies to restore quality of life.

Spine 52

Spine Spinal Manipulation Chiropractic Posture 52

OrthoSpineNews

JANUARY 7, 2025

a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc Disease (DDD), today announced that Chief Executive Officer Marc Viscogliosi will present a corporate overview and update at Biotech Showcase 2025, taking place in San Francisco January 13-15.

Degenerative Disc Disease 52

Degenerative Disc Disease Spine Prevention Treatment 52

OrthoSpineNews

JUNE 13, 2025

The data were presented as part of the Clinical Innovations track at ISSCR 2025, an event that attracts the world’s top stem cell and regenerative medicine researchers, clinicians, and investors. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease.

Degenerative Disc Disease 64

Degenerative Disc Disease Lower Back Pain Clinic Treatment 64